Juvenon, Inc. – Trademark Portfolio
Entity Type: 03
Juvenon, Inc. holds 10 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 8 filings in this category. The portfolio also extends into Class 3 (Cosmetics & Cleaning) across 4 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include Q-VERATROL. The owner is based in Orinda, CA.
21-C Orinda Way #132
Orinda, CA 945632510
Showing of trademarks Trademarks
Trademark Classifications
Juvenon, Inc.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Raw and unprocessed agricultural, aquacultural, horticultural and forestry products
Frequently Asked Questions
How many trademarks does Juvenon, Inc. have?
Juvenon, Inc. has 10 U.S. trademarks filed with the USPTO. Of these, 1 registered, 5 abandoned, 4 cancelled.
What trademark classes does Juvenon, Inc. file in?
Juvenon, Inc. files trademarks across 4 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 3 (Cosmetics & Cleaning), Class 44 (Medical Services), Class 31 (Natural Agricultural Products). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Juvenon, Inc.'s most well-known trademarks?
Juvenon, Inc.'s registered trademark portfolio includes well-known marks such as Q-VERATROL. These are among 1 currently registered trademark in the portfolio.
What is Juvenon, Inc.'s trademark registration success rate?
Juvenon, Inc. has a 10% trademark registration rate, with 1 out of 10 resolved applications resulting in successful registration. Currently, 0 applications are pending review.